Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients

Clinical trial NCT00393861 · COMPLETED

Trial details

NCT number: NCT00393861
Sponsor: Indiana University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Germ Cell and Embryonal

Start date: 2006-10-01
Primary completion: 2012-10-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.